Pfizer to Acquire Global Blood Therapeutics in $5.4bn Deal
Summary : Through the acquisition of Global Blood Therapeutics, Pfizer aims to enhance its presence in rare haematology and particularly sickle cell…
Summary : Through the acquisition of Global Blood Therapeutics, Pfizer aims to enhance its presence in rare haematology and particularly sickle cell…
Synopsis : The U.S. Food and Medication Administration (FDA) has designated PT886 as an orphan drug for the treatment of pancreatic cancer,…
Summary – A new drug recently introduced for use in the treatment of refractory/relapsed multiple myeloma looks like it will also find…